Baldassari, Laura E.
Fox, Robert J.
Article History
First Online: 25 September 2018
Compliance with Ethical Standards
:
: No funding was received for the publication of this review.
: Fox has received personal consultancy fees from Actelion, Biogen, EMD Serono, Genentech, Novartis, and Teva, and has served on advisory committees for Actelion, Biogen, and Novartis, and received clinical trial contract and research grant funding from Biogen and Novartis. Dr. Baldassari has received personal fees for serving on a scientific advisory board for Teva, and receives funding via a Sylvia Lawry Physician Fellowship Grant through the National Multiple Sclerosis Society (#FP-1606-24540).
Free to read: This content has been made available to all.